東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

New drugs and targets for asthma and...

Hansel, T. T. (1956-)

Linked to FindBook

Google Book

Amazon

博客來

New drugs and targets for asthma and COPD

Record Type:	Electronic resources : Monograph/item
Title/Author:	New drugs and targets for asthma and COPD/ volume editors, Trevor T. Hansel, Peter J. Barnes.
other author:	Hansel, T. T.
Published:	Basel :Karger, : c2010.,
Description:	1 online resource (xiv, 310 p.) :ill. (chiefly col.)
Subject:	Asthma - Chemotherapy. -
Online resource:	http://content.karger.com/produkteDB/produkte.asp?Aktion=ShowEachType&ProduktNr=254432
ISBN:	9783805595674 (electronic bk.)

New drugs and targets for asthma and COPD
New drugs and targets for asthma and COPD[electronic resource] /volume editors, Trevor T. Hansel, Peter J. Barnes. - Basel :Karger,c2010. - 1 online resource (xiv, 310 p.) :ill. (chiefly col.) - Progress in respiratory research,v. 391422-2140 ;. - Progress in respiratory research ;v.37..

Includes bibliographical references and index.

Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors. Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists.

ISBN: 9783805595674 (electronic bk.)Subjects--Topical Terms:

1602818
Asthma
--Chemotherapy.Index Terms--Genre/Form:

542853
Electronic books.

LC Class. No.: RC591 / .N497 2010

Dewey Class. No.: 616.2/38061

National Library of Medicine Call No.: W1 / PR681DM v.39 2010

New drugs and targets for asthma and COPD
LDR:02123cmm a2200289 a 4500 001 1314840
006 m d
007 cr cn|||||||||
008 121226s2010 sz ob 001 0 eng d
020 $a 9783805595674 (electronic bk.)
020 $a 3805595670 (electronic bk.)
020 $a 9786613439345
020 $a 6613439347
020 $a 9783805595667 (hc : alk. paper)
020 $a 3805595662 (hc : alk. paper)
035 $a ocn664346557
040 $a UKSKG $b eng $c UKSKG $d N $d CDX $d IDEBK $d E7B
050 4 $a RC591 $b .N497 2010
060 1 4 $a W1 $b PR681DM v.39 2010
060 1 4 $a WF 553
082 0 4 $a 616.2/38061 $2 22
245 0 0 $a New drugs and targets for asthma and COPD $h [electronic resource] / $c volume editors, Trevor T. Hansel, Peter J. Barnes.
260 $a Basel : $b Karger, $c c2010.
300 $a 1 online resource (xiv, 310 p.) : $b ill. (chiefly col.)
490 1 $a Progress in respiratory research, $x 1422-2140 ; $v v. 39
504 $a Includes bibliographical references and index.
520 $a Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors. Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists.
650 0 $a Asthma $x Chemotherapy. $3 1602818
650 0 $a Antiasthmatic agents. $3 1602819
650 1 2 $a Asthma $x drug therapy. $3 1602820
650 2 2 $a Pulmonary Disease, Chronic Obstructive $x drug therapy. $3 915570
650 2 2 $a Respiratory System Agents. $3 1602821
655 4 $a Electronic books. $2 lcsh $3 542853
700 1 $a Hansel, T. T. $q (Trevor T.), $d 1956- $3 1602817
700 1 $a Barnes, Peter J., $d 1946- $3 669058
710 2 $a S. Karger (Firm) $3 1574363
830 0 $a Progress in respiratory research ; $v v.37. $3 1360766
856 4 0 $u http://content.karger.com/produkteDB/produkte.asp?Aktion=ShowEachType&ProduktNr=254432